Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.
暂无分享,去创建一个
Sonia H Yoo | Jayakrishna Ambati | J. Ambati | A. Adamis | S. Yoo | B. Ambati | S. Ianchulev | Anthony P Adamis | Balamurali K Ambati | Sean Ianchulev
[1] B. Munoz,et al. Visible light and risk of age-related macular degeneration. , 1990, Transactions of the American Ophthalmological Society.
[2] D. Seigel. AREDS investigators distort findings. , 2002, Archives of ophthalmology.
[3] R. Müller,et al. External beam radiation in patients suffering from exudative age-related macular degeneration , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.
[4] E. Stefánsson,et al. Age related macular degeneration in monozygotic twins and their spouses in Iceland. , 1999, Acta ophthalmologica Scandinavica.
[5] C. Greven,et al. PHOTOCOAGULATION OF WELL‐DEFINED CHOROIDAL NEOVASCULARIZATION IN AGE‐RELATED MACULAR DEGENERATION:Clinicopathologic Correlation , 1998, Retina.
[6] M. Humayun,et al. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. , 2002, American journal of ophthalmology.
[7] G. Eldred,et al. Retinal age pigments generated by self-assembling lysosomotropic detergents , 1993, Nature.
[8] S. Ryan,et al. The role of retinal pigment epithelium in the involution of subretinal neovascularization. , 1986, Investigative ophthalmology & visual science.
[9] K. C. Hayes. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. , 1974, Investigative ophthalmology.
[10] W. Freeman,et al. Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration. , 2002, American journal of ophthalmology.
[11] M. Tso,et al. The protective effect of ascorbate in retinal light damage of rats. , 1985, Investigative ophthalmology & visual science.
[12] M. Sandberg,et al. Visual field deficits in early age-related macular degeneration , 1994, Vision Research.
[13] I. Raz,et al. The influence of zinc supplementation on glucose homeostasis in NIDDM. , 1989, Diabetes research.
[14] R. Elston,et al. Oral zinc in macular degeneration. , 1988, Archives of ophthalmology.
[15] D F Schorderet,et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. , 2001, Archives of ophthalmology.
[16] P Sternberg,et al. Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. , 1992, American journal of ophthalmology.
[17] R. Klein,et al. The relation of coffee and caffeine to the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. , 2001, American journal of ophthalmology.
[18] F L Ferris,et al. Senile macular degeneration: a case-control study. , 1983, American journal of epidemiology.
[19] D. P. Jones,et al. Oxidant-induced apoptosis in cultured human retinal pigment epithelial cells. , 1999, Investigative ophthalmology & visual science.
[20] Y. Courtois,et al. Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization. , 1999, Investigative ophthalmology & visual science.
[21] Gass Jd. Drusen and disciform macular detachment and degeneration. 1972. , 2003, Retina.
[22] W. Willett,et al. A prospective study of cigarette smoking and age-related macular degeneration in women. , 1996, Journal of the American Medical Association (JAMA).
[23] A C Bird,et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. , 1999, Investigative ophthalmology & visual science.
[24] M. Gillies,et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule‐1 (ICAM‐1) expression of the ECV304 cell line: implications for macular degeneration , 2000, Clinical and experimental immunology.
[25] J. Weiter,et al. Relationship of senile macular degeneration to ocular pigmentation. , 1985, American journal of ophthalmology.
[26] J. Lim,et al. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. , 2001, Investigative ophthalmology & visual science.
[27] Jennifer R. Evans,et al. Risk Factors for Age-related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[28] D A Newsome,et al. Analysis of newly synthesized Bruch's membrane proteoglycans. , 1989, Investigative ophthalmology & visual science.
[29] D. Bok,et al. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] Y. Ogura,et al. Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration. , 2000, Japanese journal of ophthalmology.
[31] N. Bressler,et al. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. 1994. , 2005, Retina.
[33] J. J. Wang,et al. Risk factors for age-related maculopathy: the Visual Impairment Project. , 2001, Archives of ophthalmology.
[34] J. Augsburger. External Beam Radiation Therapy Is Not Effective in the Treatment of Age-related Macular Degeneration , 1998 .
[35] R. Frank,et al. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. , 1994, Investigative ophthalmology & visual science.
[36] K. Fukuzawa,et al. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and α-tocopherol in liposomes , 1998, Lipids.
[37] J. Sunness,et al. Limited macular translocation for atrophic maculopathy. , 2002, Archives of ophthalmology.
[38] P T de Jong,et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.
[39] Simon C Watkins,et al. Nitric Oxide Induces Angiogenesis and Upregulates αvβ3 Integrin Expression on Endothelial Cells , 2000 .
[40] R. Frank,et al. Mitogenesis and retinal pigment epithelial cell antigen expression in the rat after krypton laser photocoagulation. , 1993, Investigative ophthalmology & visual science.
[41] J. Rakic,et al. Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] E. Friedman. A hemodynamic model of the pathogenesis of age-related macular degeneration. , 1997, American journal of ophthalmology.
[43] A. Bird,et al. The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. , 1989, American journal of ophthalmology.
[44] D. Frambach,et al. Choroidal hypoperfusion after surgical excision of subfoveal neovascular membranes in age-related macular degeneration , 2004, International Ophthalmology.
[45] S. Horiuchi,et al. Advanced glycation end products in age-related macular degeneration. , 1998, Archives of ophthalmology.
[46] M. Komada,et al. Vascular endothelial growth factor expression in choroidal neovascularization in rats , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.
[47] C. Curcio,et al. Basal linear deposit and large drusen are specific for early age-related maculopathy. , 1999, Archives of ophthalmology.
[48] D. Connolly,et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.
[49] J. Isner,et al. Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* , 1998, The Journal of Biological Chemistry.
[50] E. Voest,et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.
[51] M. Tso,et al. Antiretinal antibodies in serum of patients with age-related macular degeneration. , 1991, Ophthalmology.
[52] J. Marshall,et al. Age-related variation in the hydraulic conductivity of Bruch's membrane. , 1995, Investigative ophthalmology & visual science.
[53] Y. Tano,et al. Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. , 2000, American journal of ophthalmology.
[54] F. A. Shamsi,et al. Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. , 2001, Free radical biology & medicine.
[55] E. Jaffe,et al. Thrombospondin is the endogenous lectin of human platelets , 1982, Nature.
[56] A. Bird,et al. Correlation between lipids extracted from Bruch's membrane and age. , 1993, Ophthalmology.
[57] F. V. van Kuijk,et al. Fatty acid composition of the human macula and peripheral retina. , 1992, Investigative Ophthalmology and Visual Science.
[58] M. Metzker,et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies , 1999, Human Genetics.
[59] R W Massof,et al. Peripheral retinal function in age-related macular degeneration. , 1985, Archives of ophthalmology.
[60] P. Wiedemann,et al. Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells. , 2001, Microvascular research.
[61] D. Hinton,et al. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. , 1998, Archives of ophthalmology.
[62] P. Campochiaro,et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.
[63] C. Eckardt,et al. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.
[64] R. Klein,et al. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.
[65] K. Csaky,et al. Age as an independent risk factor for severity of experimental choroidal neovascularization. , 2002, Investigative ophthalmology & visual science.
[66] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] K Miyamoto,et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). , 2000, The American journal of pathology.
[68] K. Suzuma,et al. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. , 1999, The American journal of pathology.
[69] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[70] P. Campochiaro,et al. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. , 2002, Investigative ophthalmology & visual science.
[71] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[72] H Schatz,et al. Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. , 1989, Ophthalmology.
[73] I. Constable,et al. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. , 2002, The American journal of pathology.
[74] B. Schwartz. Monocyte synthesis of thrombospondin. The role of platelets. , 1989, The Journal of biological chemistry.
[75] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[76] P.T.V.M. de Jong,et al. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration , 1997 .
[77] H. Grossniklaus,et al. Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with age-related maculopathy. , 2000, Archives of ophthalmology.
[78] J. Kopitz,et al. Proteome analysis of lipofuscin in human retinal pigment epithelial cells , 2002, FEBS letters.
[79] B. Olsen,et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. , 1997, Investigative ophthalmology & visual science.
[80] A. Adamis,et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. , 1998, Investigative ophthalmology & visual science.
[81] A. Bird,et al. Dark adaptation in age-related macular degeneration: relationship to the fellow eye , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.
[82] A. Milam,et al. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. , 1997, The American journal of pathology.
[83] R. G. Brown,et al. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. , 1994, Metabolism: clinical and experimental.
[84] M. Figueroa,et al. LASER PHOTOCOAGULATION FOR MACULAR SOFT DRUSEN: Updated Results , 1997, Retina.
[85] R. Sperduto,et al. Systemic hypertension and age-related maculopathy in the Framingham Study. , 1986, Archives of ophthalmology.
[86] L. Yannuzzi,et al. Age-related macular degeneration and choroidal neovascularization. , 1993, American journal of ophthalmology.
[87] M. Blumenkranz,et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. , 1986, Ophthalmology.
[88] W. Shen,et al. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. , 2000, Current eye research.
[89] E. Rimm,et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. , 2000, Archives of ophthalmology.
[90] J. Folkman,et al. Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen , 1995 .
[91] P. Finger,et al. Radiotherapy and the treatment of age-related macular degeneration. External beam radiation therapy is effective in the treatment of age-related macular degeneration. , 1998, Archives of ophthalmology.
[92] K. Murayama,et al. Studies on the mechanism of early onset macular degeneration in cynomolgus (Macaca fascicularis) monkeys. I. Abnormal concentrations of two proteins in the retina. , 1996, Experimental eye research.
[93] F. Koch,et al. Detection of Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Choroidal Neovascular Membranes , 2002, Ophthalmologica.
[94] A. Hofman,et al. Age-related macular degeneration and smoking. The Rotterdam Study. , 1996 .
[95] M. Boulton,et al. Regional variation and age-related changes of lysosomal enzymes in the human retinal pigment epithelium. , 1994, The British journal of ophthalmology.
[96] R. Klein,et al. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2002, Archives of ophthalmology.
[97] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[98] J. J. Plantner,et al. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. , 1998, Experimental eye research.
[99] P. Rakoczy,et al. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy , 2002, Gene Therapy.
[100] A. Bird,et al. Retinal pigment epithelial detachments in the elderly. , 1986, Transactions of the ophthalmological societies of the United Kingdom.
[101] W R Green,et al. Senile macular degeneration: a histopathologic study. , 1977, Transactions of the American Ophthalmological Society.
[102] A C Bird,et al. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. , 1999, Archives of ophthalmology.
[103] J. Stone,et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.
[104] F. Ferris,et al. Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.
[105] P. Sternberg,et al. A donor-age-dependent change in the activity of alpha-mannosidase in human cultured RPE cells. , 1989, Investigative ophthalmology & visual science.
[106] P. Penfold,et al. Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[107] J. Handa,et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. , 1999, Investigative ophthalmology & visual science.
[108] P. Kaiser,et al. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. , 1999, American journal of ophthalmology.
[109] G. Hallmans,et al. Zinc, total protein, and albumin in CSF of patients with cerebrovascular diseases , 1986, Acta neurologica Scandinavica.
[110] D. K. Wilcox. Vectorial accumulation of cathepsin D in retinal pigmented epithelium: effects of age. , 1988, Investigative ophthalmology & visual science.
[111] M. Lavail,et al. Degenerative Retinal Diseases , 2012, Springer US.
[112] K. Miyarnoto. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .
[113] J. Cooke,et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. , 2000, Arteriosclerosis, Thrombosis and Vascular Biology.
[114] Mark S. Blumenkranz,et al. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group. , 1998, Ophthalmology.
[115] A. Nesburn,et al. Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. , 2002, Biochemical and biophysical research communications.
[116] David,et al. Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. , 1995, Investigative ophthalmology & visual science.
[117] Ivana K. Kim,et al. Diffusion of high molecular weight compounds through sclera. , 2000, Investigative ophthalmology & visual science.
[118] B. Straatsma,et al. Chorioretinal juncture. Multiple extramacular drusen. , 1986, Ophthalmology.
[119] W. Manning,et al. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. , 2003, Investigative ophthalmology & visual science.
[120] J. Slakter,et al. External beam radiation therapy for choroidal neovascularization. , 1998, Ophthalmology.
[121] G. A. Limb,et al. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. , 1999, Investigative ophthalmology & visual science.
[122] A Hofman,et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.
[123] M. Shimura,et al. Molecular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration. , 2000, Japanese journal of ophthalmology.
[124] G. Soubrane,et al. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. , 1995, Archives of ophthalmology.
[125] C. Frennesson,et al. Colour contrast sensitivity in patients with soft drusen, an early stage of ARM , 2005, Documenta Ophthalmologica.
[126] K. Bartz-Schmidt,et al. Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration , 2000, The British journal of ophthalmology.
[127] Joan W. Miller,et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. , 2002, Archives of ophthalmology.
[128] S. Kochanek,et al. Autologous transplantation of genetically modified iris pigment epithelial cells: A promising concept for the treatment of age-related macular degeneration and other disorders of the eye , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[129] J. Folk. Aging macular degeneration. Clinical features of treatable disease. , 1985, Ophthalmology.
[130] C. Curcio,et al. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. , 2000, Investigative ophthalmology & visual science.
[131] R. Bucala,et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.
[132] G. Koh,et al. Angiopoietin-1 Reduces VEGF-Stimulated Leukocyte Adhesion to Endothelial Cells by Reducing ICAM-1, VCAM-1, and E-Selectin Expression , 2001, Circulation research.
[133] Z. Radisavljevic,et al. Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[134] G. M. Hope,et al. A primate model for age related macular drusen. , 1992, The British journal of ophthalmology.
[135] B. Munoz,et al. Are antioxidants or supplements protective for age-related macular degeneration? , 1994, Archives of ophthalmology.
[136] R. Glynn,et al. Body mass index and the incidence of visually significant age-related maculopathy in men. , 2001, Archives of ophthalmology.
[137] E. de Juan,et al. Inhibition of choriocapillaris regeneration with genistein. , 1999, Investigative ophthalmology & visual science.
[138] D. Eliott,et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.
[139] B. Hammond,et al. Macular pigment density in monozygotic twins. , 1995, Investigative ophthalmology & visual science.
[140] M. Elman,et al. The natural history of serous retinal pigment epithelium detachment in patients with age-related macular degeneration. , 1986, Ophthalmology.
[141] J. Folkman,et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. , 1993, Biochemical and biophysical research communications.
[142] C. Remé,et al. Light damage in the rat retina: the effect of dietary deprivation of N-3 fatty acids on acute structural alterations. , 1991, Experimental eye research.
[143] R. E. Anderson,et al. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. , 1992, Investigative ophthalmology & visual science.
[144] M. Kuroki,et al. Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells. , 2000, Investigative ophthalmology & visual science.
[145] S. Seregard,et al. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. , 1998, Investigative ophthalmology & visual science.
[146] H. Kaplan,et al. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina , 1999, Nature Medicine.
[147] Joan W. Miller,et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.
[148] Matthew A. Thomas,et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. , 1994, Ophthalmology.
[149] R. Hanssen. III. Zur Anatomie der scheibenförmigen Degeneration der Netzhautmitte , 1930 .
[150] H. Grossniklaus,et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.
[151] M. Delmelle,et al. RETINAL SENSITIZED PHOTODYNAMIC DAMAGE TO LIPOSOMES , 1978, Photochemistry and photobiology.
[152] Joan W. Miller,et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.
[153] Potter Jw,et al. Geographic atrophy of the retinal pigment epithelium: diagnosis and vision rehabilitation. , 1981 .
[154] J. Wood,et al. The influence of zinc on caspase-3 and DNA breakdown in cultured human retinal pigment epithelial cells. , 2001, Archives of ophthalmology.
[155] Y. Tsao,et al. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. , 2001, Investigative ophthalmology & visual science.
[156] J. Lupski,et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.
[157] S. Fine,et al. Prognosis of patients with bilateral macular drusen. , 1984, Ophthalmology.
[158] I. Constable,et al. Modulation of cathepsin D activity in retinal pigment epithelial cells. , 1997, The Biochemical journal.
[159] P. Gouras,et al. Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.
[160] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[161] H. Takagi,et al. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. , 2001, Diabetes.
[162] J. Weiter,et al. Classification of retinal pigment epithelial detachments associated with drusen , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[163] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[164] W. Willett,et al. Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.
[165] J. Handa,et al. β-Galactosidase histochemistry and telomere loss in senescent retinal pigment epithelial cells , 1999 .
[166] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[167] E. de Juan,et al. Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse. , 2000, Investigative ophthalmology & visual science.
[168] M. Killingsworth,et al. Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.
[169] R. Klein,et al. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. , 2001, Archives of ophthalmology.
[170] S M Meyers,et al. A twin study of age-related macular degeneration. , 1995, American journal of ophthalmology.
[171] G. Clover,et al. The effect of age on the macromolecular permeability of human Bruch's membrane. , 2001, Investigative ophthalmology & visual science.
[172] Paul S. Bernstein,et al. Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration , 1997 .
[173] E. Friedman,et al. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. , 2000, American journal of ophthalmology.
[174] Gass Jd. Drusen and disciform macular detachment and degeneration. , 1972 .
[175] J. Handa,et al. Senescence-associated β-galactosidase histochemistry for the primate eye , 1999 .
[176] M. Thun,et al. Multivitamin use and mortality in a large prospective study. , 2000, American journal of epidemiology.
[177] P. D. de Jong,et al. Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.
[178] A. Ho,et al. Foveolar choroidal blood flow in age-related macular degeneration. , 1998, Investigative ophthalmology & visual science.
[179] R. D'Amato,et al. Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[180] E. Midena,et al. Macular drusen and the sensitivity of the central visual field , 2005, Documenta Ophthalmologica.
[181] M. Uyama,et al. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. , 1996, Current eye research.
[182] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[183] W. Lee,et al. Basal linear deposit in the human macula , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[184] M. L. Le Beau,et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[185] J S Sunness,et al. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. , 1999, Ophthalmology.
[186] M G Maguire,et al. Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. , 1999, Ophthalmology.
[187] S. Ryan,et al. Subretinal neovascularization. Natural history of an experimental model. , 1982, Archives of ophthalmology.
[188] H. Hammes,et al. Nε(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration , 1999 .
[189] D. Weeks,et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. , 2001, American journal of ophthalmology.
[190] D. Hinton,et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.
[191] E. Dratz,et al. A reinvestigation of the fatty acid content of bovine, rat and frog retinal rod outer segments. , 1979, Experimental eye research.
[192] H. Adlercreutz,et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[193] H. Krutzsch,et al. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. , 2000, Investigative ophthalmology & visual science.
[194] A. Bird,et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. , 1992, Ophthalmology.
[195] J. Handa,et al. The mRNA phenotype of a human RPE cell line at replicative senescence. , 1999, Molecular vision.
[196] A Kijlstra,et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, American Journal of Pathology.
[197] J. Weiter,et al. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. , 1978, Investigative ophthalmology & visual science.
[198] A. Berghold,et al. Morphologic characteristics of disciform scarring after radiation treatment for age-related macular degeneration. , 2000, Ophthalmology.
[199] O. Volpert,et al. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. , 2002, American journal of ophthalmology.
[200] S Berman,et al. Retinal damage by light in rats. , 1966, Investigative ophthalmology.
[201] D. Anthony,et al. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. , 1997, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[202] M. Killingsworth,et al. RETICULAR PSEUDODRUSEN: A Risk Factor in Age-Related Maculopathy , 1995, Retina.
[203] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[204] P. Campochiaro,et al. VEGF is major stimulator in model of choroidal neovascularization. , 2000, Investigative ophthalmology & visual science.
[205] M. Tso,et al. Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. , 1985, Archives of ophthalmology.
[206] R. Klein,et al. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. , 1998, American journal of epidemiology.
[207] C. D. Hartranft,et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. , 2000, American journal of ophthalmology.
[208] C. Wormington. The Rhesus Monkey as an Animal Model for Age-Related Maculopathy , 1990, Optometry and vision science : official publication of the American Academy of Optometry.
[209] M. Sanz,et al. Cyclic AMP elevating agents and nitric oxide modulate angiotensin II‐induced leukocyte‐endothelial cell interactions in vivo , 2001, British journal of pharmacology.
[210] W. Gordon,et al. Rapid and selective uptake, metabolism, and cellular distribution of docosahexaenoic acid among rod and cone photoreceptor cells in the frog retina , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[211] D. Easty,et al. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. , 1995, The British journal of ophthalmology.
[212] G. Hageman,et al. Molecular composition of drusen as related to substructural phenotype. , 1999, Molecular vision.
[213] N. Taichman,et al. Human neutrophils secrete vascular endothelial growth factor , 1997, Journal of leukocyte biology.
[214] U. Brunk,et al. Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content. , 2001, Free radical biology & medicine.
[215] R J Glynn,et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.
[216] P. Campochiaro,et al. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). , 2001, Human gene therapy.
[217] P Darzins,et al. Sun exposure and age-related macular degeneration. An Australian case-control study. , 1997, Ophthalmology.
[218] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[219] J. Handa,et al. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. , 2001, Investigative ophthalmology & visual science.
[220] K. Dutt,et al. Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitro , 1995, Journal of cellular physiology.
[221] J. Manson,et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. , 2001, Archives of ophthalmology.
[222] Y Ikada,et al. A new model of subretinal neovascularization in the rabbit. , 1995, Investigative ophthalmology & visual science.
[223] G. Jerums,et al. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes , 2000, Diabetologia.
[224] R. Fisher. The influence of age on some ocular basement membranes , 1987, Eye.
[225] V. Sheffield,et al. An analysis of allelic variation in the ABCA4 gene. , 2001, Investigative ophthalmology & visual science.
[226] B. Olsen,et al. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. , 1994, Genomics.
[227] A. Bird,et al. Long-term drusen study. , 1999, Retina.
[228] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[229] N. Bouck,et al. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[230] U. Brunk,et al. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. , 1997, Free radical biology & medicine.
[231] I. Constable,et al. Preclinical Evaluation of a Phosphorothioate Oligonucleotide in the Retina of Rhesus Monkey , 2002, Laboratory Investigation.
[232] K Miyamoto,et al. Transscleral delivery of bioactive protein to the choroid and retina. , 2000, Investigative ophthalmology & visual science.
[233] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[234] M. Gillies,et al. Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[235] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[236] H. Ueno,et al. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration , 2000, Gene Therapy.
[237] T. Cox,et al. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. , 2002, Experimental eye research.
[238] Yu-Sheng Chao,et al. Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering , 2001 .
[239] R. Klein,et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. , 1998, American journal of epidemiology.
[240] P. D. de Jong,et al. Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. , 1993, The British journal of ophthalmology.
[241] B. Lorenz,et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. , 2000, American journal of human genetics.
[242] Greene Wr. Histopathology of age-related macular degeneration. , 1999, Molecular vision.
[243] S. Sonoda,et al. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. , 2000, American journal of ophthalmology.
[244] A. Deutman,et al. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.
[245] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[246] S. Bernstein,et al. Heat shock cognate-70 gene expression declines during normal aging of the primate retina. , 2000, Investigative ophthalmology & visual science.
[247] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[248] A. Bird,et al. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. , 1992, Investigative ophthalmology & visual science.
[249] H. Takagi,et al. Expressions of Angiopoietins and Tie2 in Human Choroidal Neovascular Membranes , 2022 .
[250] P. Tsao,et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis , 2001, Nature Medicine.
[251] J. Provis,et al. Autoantibodies to retinal astrocytes associated with age-related macular degeneration , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[252] S. Ryan,et al. Correlation of choroidal subretinal neovascularization with fluorescein angiography. , 1985, American journal of ophthalmology-glaucoma.
[253] M. Humayun,et al. Complications associated with limited macular translocation. , 2000, American journal of ophthalmology.
[254] A. Hofman,et al. Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.
[255] P Esser,et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. , 2000, Archives of ophthalmology.
[256] H. Yamamoto,et al. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. , 1998, International journal of oncology.
[257] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[258] S. Cringle,et al. The effect of the retinal circulation on vitreal oxygen tension. , 1985, Current eye research.
[259] W. Freeman,et al. Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration. , 1999, Retina.
[260] Y. Tano,et al. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. , 1996, American journal of ophthalmology.
[261] J. Slakter,et al. RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION , 2001, Retina.
[262] A Hofman,et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.
[263] N. Bressler,et al. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.
[264] B S Hawkins,et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. , 1997, Ophthalmology.
[265] Y. Courtois,et al. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. , 2001, The Journal of clinical investigation.
[266] Charles D. McDermott,et al. Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials , 1999, Annals of the New York Academy of Sciences.
[267] E. Rimm,et al. Prospective study of dietary fat and the risk of age-related macular degeneration. , 2001, The American journal of clinical nutrition.
[268] E. Bauer,et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.
[269] E S Gragoudas,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[270] T. Hikichi,et al. Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats. , 2001, American journal of ophthalmology.
[271] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[272] U. Brunk,et al. Lipofuscin accumulation in cultured retinal pigment epithelial cells reduces their phagocytic capacity. , 1998, Current eye research.
[273] R. Klein,et al. Dietary fat and age-related maculopathy. , 1995, Archives of ophthalmology.
[274] G. Hageman,et al. Histochemical Comparison of Ocular “Drusen” in Monkey and Human , 1997 .
[275] W. Heriot,et al. Ultrastructure of Bruch's membrane after krypton laser photocoagulation. II. Repair of Bruch's membrane and the role of macrophages. , 1986, Archives of ophthalmology.
[276] J. Quivey,et al. Randomized trial of radiation for age-related macular degeneration. , 1999, American journal of ophthalmology.
[277] R. Danis,et al. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration , 2002, The British journal of ophthalmology.
[278] J. J. Wang,et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.
[279] H. Grossniklaus. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Ranson NT, Danis RP, ∗ Ciulla TA, Pratt L. Br J Ophthalmol 2002;86:527–529 , 2002 .
[280] R. Allikmets,et al. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. , 2000, American journal of human genetics.
[281] C K Dorey,et al. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. , 2001, Investigative ophthalmology & visual science.
[282] J. Grunwald,et al. Effect of aging on foveolar choroidal circulation. , 1998, Archives of ophthalmology.
[283] Y. Arsenijévic,et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[284] J. Neitz,et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. , 2001, American journal of ophthalmology.
[285] R. Klein,et al. Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye study , 1994, Genetic epidemiology.
[286] P. Maguire,et al. Geographic atrophy of the retinal pigment epithelium. , 1986, American journal of ophthalmology.
[287] J. J. Wang,et al. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. , 1998, Archives of ophthalmology.
[288] C. Delcourt,et al. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. , 1998, Archives of ophthalmology.
[289] P. Ballinari,et al. A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration , 2001, Documenta Ophthalmologica.
[290] T. G. Truscott,et al. The carotenoids as anti-oxidants--a review. , 1997, Journal of photochemistry and photobiology. B, Biology.
[291] B. Polak,et al. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. , 1995, The British journal of ophthalmology.
[292] B. Kirchhof,et al. Iris pigment epithelial cell translocation in exudative age-related macular degeneration , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.
[293] H. Little,et al. A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. , 1997, Ophthalmology.
[294] Judith Alexander,et al. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. , 1997, Archives of ophthalmology.
[295] K. Csaky,et al. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. , 2000, Investigative ophthalmology & visual science.
[296] Y. Zou,et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.
[297] E. Midena,et al. Macular function impairment in eyes with early age-related macular degeneration. , 1997, Investigative Ophthalmology and Visual Science.
[298] T. Otsuji,et al. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. , 1999, Current eye research.
[299] Familial Aggregation of Age-related Maculopathy , 1997 .
[300] S. Nilsson,et al. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. , 2001, Free radical biology & medicine.
[301] M. Boulton,et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.
[302] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[303] R. Nitsch,et al. CST3 genotype associated with exudative age related macular degeneration , 2002, The British journal of ophthalmology.
[304] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[305] Andreas Wenzel,et al. Age-related Macular Degeneration , 2000, The Journal of Biological Chemistry.
[306] P. Campochiaro,et al. Role of hypoxia and extracellular matrix‐integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells , 1999 .
[307] P. D. de Jong,et al. Macular pigment and melanin in age-related maculopathy in a general population. , 2002, Investigative ophthalmology & visual science.
[308] Lawrence A. Yannuzzi,et al. PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION , 2002, Retina.
[309] Y. Mori,et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. , 2001, Circulation research.
[310] J. Slakter,et al. Sub-Tenon’s Administration of the Angiostatic Agent Anecortave Acetate in AMD Patients with Subfoveal Choroidal Neovascularization (CNV) - the Clinical Outcome , 2002 .
[311] Ian J Constable,et al. Lipofuscin of the retinal pigment epithelium: A review , 1995, Eye.
[312] K. Suzuma,et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. , 1999, Investigative ophthalmology & visual science.
[313] I. Morita,et al. Novel mechanism for age‐related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF , 2001, Journal of cellular physiology.
[314] A. Bird,et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. , 1994, Archives of ophthalmology.
[315] F. Topouzis,et al. Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity. , 1995, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[316] P. Campochiaro,et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. , 2002, Investigative ophthalmology & visual science.
[317] Joan W. Miller,et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[318] Macular Translocation With 360° Retinotomy for Exudative Age-Related Macular Degeneration , 2002 .
[319] P. Mitchell,et al. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. , 2002, Archives of ophthalmology.
[320] B. Munoz,et al. Exposure to sunlight and other risk factors for age-related macular degeneration. , 1989, Archives of ophthalmology.
[321] H. Chen,et al. An immunologic study on age-related macular degeneration. , 1993, Yan ke xue bao = Eye science.
[322] K. Nakagawa,et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.
[323] P. Campochiaro,et al. Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina , 2000, Journal of cellular physiology.
[324] J D Gass,et al. Drusen and disciform macular detachment and degeneration. , 1973, A M A Archives of Ophthalmology.
[325] D. Connolly,et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.
[326] Matthew A. Thomas,et al. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. , 2000, American journal of ophthalmology.
[327] M. Uyama,et al. Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization. , 1997, Current eye research.
[328] M G Maguire,et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. , 1995, Archives of ophthalmology.
[329] C. Masters,et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.
[330] C. K. Chan,et al. Systemically expressed soluble Tie2 inhibits intraocular neovascularization. , 2001, Human gene therapy.
[331] M. Kessler,et al. MACULAR DEGENERATION IN A COMMUNITY OF RHESUS MONKEYS: Ultrastructural Observations , 1987, Retina.
[332] A. Tsujikawa,et al. CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. , 2000, The American journal of pathology.
[333] I. Shiojima,et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. , 2000, Nature Medicine.
[334] E. Rimm,et al. Prospective study of zinc intake and the risk of age-related macular degeneration. , 2001, Annals of epidemiology.
[335] K. Fujiki,et al. Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. , 1996, Experimental eye research.
[336] M. Killingsworth,et al. Evolution of geographic atrophy of the retinal pigment epithelium , 1988, Eye.
[337] Jayakrishna Ambati,et al. Transscleral drug delivery to the retina and choroid , 2002, Progress in Retinal and Eye Research.
[338] Chandra L. Theesfeld,et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[339] S. Wolf,et al. Angiographic findings in patients with exudative age-related macular degeneration , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.
[340] J. Weiter,et al. CELL LOSS IN THE AGING RETINA , 1989 .
[341] D. Bok. Retinal photoreceptor-pigment epithelium interactions. Friedenwald lecture. , 1985, Investigative ophthalmology & visual science.
[342] L A Yannuzzi,et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. , 2000, Ophthalmology.
[343] Joan W. Miller,et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. , 1997, Archives of ophthalmology.
[344] J. de Laey,et al. Neovascularization after argon laser photocoagulation of macular lesions. , 1975, American journal of ophthalmology.
[345] P. Campochiaro,et al. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. , 2001, The American journal of pathology.
[346] Jian-xing Ma,et al. Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization , 2001, FEBS letters.
[347] N. Bressler,et al. Choroidal neovascularization in black patients. , 1994, Archives of ophthalmology.
[348] M. Cooper,et al. Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System , 2000, Hypertension.
[349] J L Edelman,et al. Quantitative image analysis of laser-induced choroidal neovascularization in rat. , 2000, Experimental eye research.
[350] D. S. Mcleod,et al. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. , 2002, Investigative ophthalmology & visual science.
[351] L. Yannuzzi,et al. Treatment of angiomatous lesions of the retina with photodynamic therapy. , 2002, Retina.
[352] P. Campochiaro,et al. Nitric oxide is proangiogenic in the retina and choroid * , 2002, Journal of cellular physiology.
[353] H. Taylor,et al. Vitamin E supplementation and macular degeneration: randomised controlled trial , 2002, BMJ : British Medical Journal.
[354] T. Ishibashi,et al. Pathogenesis of laser-induced choroidal subretinal neovascularization. , 1990, Investigative ophthalmology & visual science.
[355] Thomas N. Sato,et al. Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.
[356] P. Huang,et al. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. , 2001, Investigative ophthalmology & visual science.
[357] W. Shen,et al. In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye , 2001, The journal of gene medicine.
[358] F. Kruse,et al. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. , 1999, Investigative ophthalmology & visual science.
[359] F. Kruse,et al. In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis. , 1999, Investigative ophthalmology & visual science.
[360] R. Klein,et al. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. , 1993, Archives of ophthalmology.
[361] M L Bots,et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. , 1995, American journal of epidemiology.
[362] Carine Munaut,et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. , 2002, The American journal of pathology.
[363] G. Soubrane,et al. Translocation of the macula for management of subfoveal choroidal neovascularization: comparison of results in age-related macular degeneration and degenerative myopia. , 2001, American journal of ophthalmology.
[364] Tomomi Sato,et al. The phytoestrogen genistein induces thymic and immune changes: A human health concern? , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[365] A. Bird,et al. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. , 1993, The British journal of ophthalmology.
[366] A. Richardson,et al. The expression of heat shock protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects. , 1998, Experimental cell research.
[367] M. P. Hartmann,et al. Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig. , 1994, Current eye research.
[368] A C Bird,et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. , 1994, Ophthalmology.
[369] M. Yanoff,et al. Artificial senescence of bovine retinal pigment epithelial cells induced by near-ultraviolet in vitro , 1999, Mechanisms of Ageing and Development.
[370] J. Provis,et al. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[371] W. Green,et al. Light-induced deposits in Bruch's membrane of protoporphyric mice. , 1993, Archives of ophthalmology.
[372] R. Guymer,et al. Influence of laser photocoagulation on choroidal capillary cytoarchitecture , 2001, The British journal of ophthalmology.
[373] S. Davies,et al. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. , 2000, Investigative ophthalmology & visual science.
[374] P. Campochiaro,et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. , 1998, The American journal of pathology.
[375] P. D. de Jong,et al. The APO*E3-Leiden mouse as an animal model for basal laminar deposit , 2000, The British journal of ophthalmology.
[376] G. Lang,et al. Thalidomide and Prednisolone Inhibit Growth Factor-Induced Human Retinal Pigment Epithelium Cell Proliferation in vitro , 2001, Ophthalmologica.
[377] A. Bird,et al. Retinal pigment epithelial detachments in the elderly: classification and outcome. , 1985, The British journal of ophthalmology.
[378] M. C. Leske,et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.
[379] Gui-Shuang Ying,et al. The role of apoptosis in age-related macular degeneration. , 2002, Archives of ophthalmology.
[380] S. Ohno,et al. Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration. , 1999, American journal of ophthalmology.
[381] I J Constable,et al. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. , 2000, The American journal of pathology.
[382] Y. Ikada,et al. Active drug targeting with immunoconjugates to choroidal neovascularization , 2000, Current eye research.
[383] A. Munnich,et al. The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .
[384] P. Campochiaro,et al. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina , 1999, Journal of cellular physiology.
[385] P. Mitchell,et al. Smoking and age-related maculopathy. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.
[386] S. P. Becerra,et al. Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing. , 1996, Investigative ophthalmology & visual science.
[387] R. Wyszynski,et al. Age-related changes of glycosidases in human retinal pigment epithelium. , 1996, Current eye research.
[388] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[389] Mark D. Johnson,et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase , 1994, Journal of cellular physiology.
[390] L. Feeney-Burns,et al. Autoradiographic studies of aged primate macular retinal pigment epithelium. , 1992, Investigative Ophthalmology and Visual Science.
[391] K. Nakanishi,et al. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. , 2000, Investigative ophthalmology & visual science.
[392] Mary A. Johnson,et al. Retinal sensitivity over drusen and nondrusen areas. A study using fundus perimetry. , 1988, Archives of ophthalmology.
[393] P. Mitchell,et al. Dietary fat and fish intake and age-related maculopathy. , 2000, Archives of ophthalmology.
[394] L. Bynoe,et al. Hematogenous photosensitization. A mechanism for the development of age-related macular degeneration. , 1990, Investigative ophthalmology & visual science.
[395] A. Munnich,et al. ABCR gene analysis in familial exudative age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.
[396] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[397] J. Shiloach,et al. Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor. , 1993, The Journal of biological chemistry.
[398] D. Shima,et al. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability , 1995, FEBS letters.
[399] P. Gouras,et al. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.
[400] H. Syddall,et al. Risk of macular degeneration in users of statins: cross sectional study , 2001, BMJ : British Medical Journal.
[401] G. Soubrane,et al. Indocyanine green angiography of drusen. , 1997, American journal of ophthalmology.
[402] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[403] M. Kamei,et al. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.
[404] P. Campochiaro,et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.
[405] T. Matise,et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.
[406] Amy S. Lee,et al. Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. , 1998, Journal of the National Cancer Institute.
[407] I. Shami. Smoking and age-related maculopathy , 1997 .
[408] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[409] E. Rodriguez-Boulan,et al. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[410] E. Berman,et al. Lipids in human lipofuscin-enriched subcellular fractions of two age populations. Comparison with rod outer segments and neural retina. , 1990, Investigative ophthalmology & visual science.
[411] D. Abramson,et al. High-dose supplements for age-related macular degeneration: did you leave out centrum? , 2002, Archives of ophthalmology.
[412] S. Russell,et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[413] W. Fung. Interferon alpha 2a for treatment of age-related macular degeneration. , 1991, American journal of ophthalmology.
[414] Harold Snieder,et al. Genetic influence on early age-related maculopathy: a twin study. , 2002, Ophthalmology.
[415] S. Sarks,et al. Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.
[416] M. Trese,et al. Evaluation of the Peripherin/RDS Gene as a Candidate Gene in Families with Age-Related Macular Degeneration , 1999, Ophthalmologica.
[417] J. Blanks,et al. Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. , 1996, Investigative ophthalmology & visual science.
[418] M. Tso,et al. Amelioration of photic injury in rat retina by ascorbic acid: a histopathologic study. , 1985, Investigative ophthalmology & visual science.
[419] M. Killingsworth,et al. Softening of drusen and subretinal neovascularization. , 1980, Transactions of the ophthalmological societies of the United Kingdom.
[420] M. Killingsworth,et al. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.
[421] M. Boulton,et al. Blue Light-induced Reactivity of Retinal Age Pigment , 1995, The Journal of Biological Chemistry.
[422] P. Campochiaro,et al. Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.
[423] J. Gilbert,et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. , 1999, Ophthalmology.
[424] A. Bird,et al. The pathogenesis of tears of the retinal pigment epithelium. , 1988, American journal of ophthalmology.
[425] K. Chalam,et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. , 1998, Ophthalmology.
[426] A. Elsner,et al. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. , 1996, Ophthalmology.
[427] Paul Mitchell,et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[428] H. Hammes,et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization , 1996, Nature Medicine.
[429] M. Lonchampt,et al. Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II. , 2001, Investigative ophthalmology & visual science.
[430] C. Curcio,et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.
[431] W R Green,et al. Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.
[432] R. Klein,et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. , 1999, Archives of ophthalmology.
[433] S. Ryan,et al. Activated macrophages in experimental subretinal neovascularization. , 1990, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[434] R. Klein,et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. , 1995, Archives of ophthalmology.
[435] B. Godley,et al. Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells , 2001, Current eye research.
[436] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[437] Judy H. Seaber,et al. Adaptation to monocular torsion after macular translocation , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.
[438] M. Sanz,et al. Reactive oxygen species mediate angiotensin II‐induced leukocyte‐endothelial cell interactions in vivo , 2001, Journal of leukocyte biology.
[439] R. Klein,et al. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[440] J. Tombran-Tink,et al. Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes. , 2002, Biochemical and biophysical research communications.
[441] E. Gaillard,et al. PHOTOPHYSICAL STUDIES ON HUMAN RETINAL LIPOFUSCIN , 1995, Photochemistry and photobiology.
[442] K. Gitter,et al. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration. , 1998, American journal of ophthalmology.
[443] C. Toth,et al. MACULAR TRANSLOCATION WITH 360-DEGREE PERIPHERAL RETINECTOMY: Impact of Technique and Surgical Experience on Visual Outcomes , 2001, Retina.
[444] R. D'Amato,et al. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. , 2001, The American journal of pathology.
[445] S. Seregard,et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.
[446] B. Godley,et al. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. , 1999, Experimental eye research.
[447] J. Sunness,et al. IMPROVEMENT OF VISUAL ACUITY OVER TIME IN PATIENTS WITH BILATERAL GEOGRAPHIC ATROPHY FROM AGE‐RELATED MACULAR DEGENERATION , 2000, Retina.
[448] V. Rajaratnam,et al. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. , 2001, Investigative ophthalmology & visual science.
[449] B. Hawkins,et al. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: II. Quality of life outcomes submacular surgery trials pilot study report number 2. , 2000, American journal of ophthalmology.
[450] F. Kruse,et al. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.
[451] K. Suzuma,et al. Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[452] Judah Folkman,et al. Thalidomide is an inhibitor of angiogenesis. , 1994 .
[453] K. Bartz-Schmidt,et al. Oxidation causes melanin fluorescence. , 2001, Investigative ophthalmology & visual science.
[454] S. Line,et al. Trace Element Status and Free Radical Defense in Elderly Rhesus Macaques (Macaca mulatta) with Macular Drusen , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[455] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[456] J. Ambati,et al. Age-related eye disease study caveats. , 2002, Archives of ophthalmology.
[457] S. Nilsson,et al. Laser Photocoagulation of Soft Drusen in Early Age-Related Maculopathy (Arm). the One-Year Results of a Prospective, Randomised Trial , 1996, European journal of ophthalmology.
[458] K. Suzuma,et al. 17 β-Estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells , 1999 .
[459] S. Ryan,et al. Newly-formed subretinal vessels. Fine structure and fluorescein leakage. , 1986, Investigative ophthalmology & visual science.
[460] Masaru Miyagi,et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[461] N. Bazan. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. , 1989, Progress in clinical and biological research.
[462] J. Haines,et al. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. , 1997, Investigative ophthalmology & visual science.
[463] W. Schalch. Carotenoids in the retina--a review of their possible role in preventing or limiting damage caused by light and oxygen. , 1992, EXS.
[464] R. Klein,et al. Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. , 2001, Archives of ophthalmology.
[465] R. Danis,et al. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. , 2001, Archives of ophthalmology.
[466] L. Aiello,et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[467] D. Trune,et al. Morphometric analysis of human retinal pigment epithelium: correlation with age and location. , 1993, Current eye research.
[468] S. Szabó,et al. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. , 1985, Science.
[469] S. Hagan,et al. Cultured human retinal pigment epithelial cells differentially express thrombospondin-1, -2, -3, and -4. , 2000, The international journal of biochemistry & cell biology.
[470] C Bellman,et al. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.
[471] R. Jain,et al. During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.
[472] Lois E. H. Smith,et al. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. , 1996, Archives of ophthalmology.
[473] R. Klein,et al. Early age-related maculopathy in the cardiovascular health study. , 2003, Ophthalmology.
[474] M. Klein,et al. Heredity and age-related macular degeneration. Observations in monozygotic twins. , 1994, Archives of ophthalmology.
[475] J. J. Wang,et al. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. , 1998, Ophthalmology.
[476] Y. Tabata,et al. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat. , 2001, Investigative ophthalmology & visual science.
[477] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[478] D. Friedman,et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. , 1999, Ophthalmology.
[479] J. Weiter,et al. Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. , 1989, Investigative ophthalmology & visual science.
[480] P. D. de Jong,et al. Risk of macular degeneration with statin use should be interpreted with caution , 2001, BMJ : British Medical Journal.
[481] P. Campochiaro,et al. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[482] M. Kase,et al. Advanced glycation end products induce angiogenesis in vivo. , 2002, Microvascular research.
[483] N. Bressler,et al. Clinical characteristics of choroidal neovascular membranes. , 1987, Archives of ophthalmology.
[484] V. Sheffield,et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy , 1999, Nature Genetics.
[485] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[486] S. Itohara,et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. , 2003, Investigative ophthalmology & visual science.
[487] M. Killingsworth,et al. Evolution of soft drusen in age-related macular degeneration , 1994, Eye.
[488] G. Chader,et al. Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. , 1995, Protein expression and purification.
[489] H. Kaplan,et al. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. , 1995, American journal of ophthalmology.
[490] F. A. Shamsi,et al. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. , 2001, Investigative ophthalmology & visual science.